Skip to main content

and
  1. Article

    Open Access

    Gemcitabine as chemotherapy of head and neck cancer in Fanconi anemia patients

    Fanconi anemia (FA) is a rare hereditary disease resulting from an inactivating mutation in the FA/BRCA pathway, critical for the effective repair of DNA interstrand crosslinks (ICLs). The disease is character...

    Anne M. van Harten, Ronak Shah, D. Vicky de Boer, Marijke Buijze in Oncogenesis (2024)

  2. Article

    Open Access

    Chemopreventive targeted treatment of head and neck precancer by Wee1 inhibition

    HPV-negative head and neck squamous cell carcinomas (HNSCCs) develop in precancerous changes in the mucosal lining of the upper-aerodigestive tract. These precancerous cells contain cancer-associated genomic c...

    Anne M. van Harten, D. Vicky de Boer, Sanne R. Martens-de Kemp in Scientific Reports (2020)